Browse by Journal or Publication Title

Garvican, L and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2004) A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes. Diabetic Medicine, 21 (10). pp. 1066-1074. doi:10.1111/j.1464-5491.2004.01300.x

Harding, S, Greenwood, R, Aldington, S, Gibson, J, Owens, D, Taylor, R, Kohner, E, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Leese, G (2003) Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabetic Medicine, 20 (12). pp. 965-971. doi:10.1111/j.1464-5491.2003.01077.x

Moreton, R B, Stratton, I M, Chave, S J, Lipinski, H and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2017) Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabetic Medicine, 34 (7). pp. 993-999. doi:10.1111/dme.13350

Oke, J L, Stratton, I M, Aldington, S J, Stevens, R J and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2016) The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme. Diabetic Medicine, 33 (7). pp. 896-903. doi:10.1111/dme.13053

Sallam, A, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, I M, Jones, V, Martin, C N, Brelen, M and Johnston, R L (2011) Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy. Diabetic Medicine, 28 (6). pp. 741-746. doi:10.1111/j.1464-5491.2011.03273.x

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2012) The preferences of people with diabetes for diabetic retinopathy screening. Diabetic Medicine, 29 (7). pp. 836-837. doi:10.1111/j.1464-5491.2012.03630.x

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Aldington, S. J. and Stratton, I. M. (2013) Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabetic Medicine, 31 (4). pp. 439-442. doi:10.1111/dme.12313

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Loftus, J, Starita, C. and Stratton, I M (2015) The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial. Diabetic Medicine, 32 (1). pp. 97-101. doi:10.1111/dme.12593

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Malhotra, R, Thomas, G, Foy, C, Kirkpatrick, J N, Lewis-Barned, N, Harney, B and Aldington, S J (2003) The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabetic Medicine, 20 (6). pp. 467-474.

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Martin, M. L., Bailey, C., Johnson, E., Hykin, P. and Keightley, S. (2006) Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy. Diabetic Medicine, 23 (1). pp. 60-66. doi:10.1111/j.1464-5491.2005.01736.x

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, I M, Leese, G P, Bachmann, M O, Land, M, Jones, C and Ferguson, B (2016) Screening attendance, age group and diabetic retinopathy level at first screen. Diabetic Medicine, 33 (7). pp. 904-911. doi:10.1111/dme.12957

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Stratton, I. M., Bachmann, M. O., Jones, C. and Leese, G. P. (2016) Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age. Diabetic Medicine, 33 (12). pp. 1655-1658. doi:10.1111/dme.13263

Smith, J.J., Wright, D.M., Scanlon, Peter H. ORCID: 0000-0001-8513-710X and Lois, N. (2020) Risk Factors Associated with Progression to Referable Retinopathy: A Type 2 Diabetes Mellitus Cohort Study in the Republic of Ireland. Diabetic Medicine, 37 (6). pp. 1000-1007. doi:10.1111/dme.14278

West, S D, Groves, D C, Lipinski, H J, Nicoll, D J, Mason, R H, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Stradling, J R (2010) The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabetic Medicine, 27 (4). pp. 423-430. doi:10.1111/j.1464-5491.2010.02962.x